London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
MaverickD - Well done for collecting some of the fruit ;-)
GLSR
Stockraiser - correct me if I'm wrong, but if MaverickD "managed to bag 150k at 2.5p", I don't see ANY fruit being collected at this stage with the bid @ 2.4p. Not forgetting commission costs on top of that. Unless you refer to rotten apples of course?
Thank you sellers…. Savvy buyers loading in the dip, funding won’t be an issue if they get FDA approval on 7th June, also the fact the bod say they are funded until early 2024…. They can’t issue an rns stating that if they are not… and the results are up to 31st December 2022, since then we have had Lanstead payments, Orion payment, next to no admin costs etc. more shares bought than sold today if that doesn’t tell you where this is heading I don’t know what does
Lets see where the price is in the next week, then we'll know if it was fruit or rotten fruit.
You take care.
SR
FDA meeting on Tuesday 16th May for CIDP…. Positive news here sees IMM back above 3.5p in the blink of an eye, $3 billion market, Orphan drug designation to be submitted, then we push forward to the main event in 7th June for Lupozor phase 3 approval, both these get approved and we are well over 10p by mid June imo
Lambo222 - See you're up to your usual hokey cokey tricks again. In out, in out, shake it all about.
Lambo you do make me giggle with your trading . Think get rid of lambo name and call yourself ..I last five mins --- Then i go in again for another trade .
Lambo enjoys talking nonsense ....even believing that his posted opinion is actually what he thinks...is a risky path to take
Just so long as Lambo realises. like us all, the RISK!/Reward ratio here and can, like us all, afford to lose all his investment
in the possible event that IMM comes to nothing. Hopefully that will not occur but people who keep averaging down all the time are, of course, increasing their dependence on the stock all the time.
OBNW - Certainly not criticising anyone, but some of my best trades have come from instances where I have averaged down. You know, where I have not managed to get in at the bottom on first attempt! Of course when I talk about trades, some trades may be over a period of months. First book I read on investing was 'The Naked Trader', and If I had listened to the advice of Mr. Burns, which was to never average down, then I would never have made the gains I have over the years.
GL SR
Averaging down can work. Equally, it can lead to bigger losses. What's undeniable is that it increases your exposure to a narrower range of shares than if you'd spread things thinner. Which heightens the risk, as well as any potential reward.
I know this share like the back of my hand, a day like today is perfect for picking up some cheap shares ahead of two major inflection points, 16th May FDA meeting for CIDP, 7th June FDA meeting to approve Lupozor phase 3, we get both of these then what is a company worth that has two phase 2/3 trials going in multi billion dollar potential markets, with Lupozor funded for $25m by Avion….. 10p and well north of 10p would be my guess especially with the Lupus market in desperate need of new drugs, a nice licensing deal for CIDP and an upfront cash payment to IMM is what they have planned and if that comes off there won’t be the need for any more dilution, even a small £5m upfront licensing payment would cover IMM for 2 years! Lots to look forward to over the next month, 2 huge company making catalysts, appproval on Tuesday and we will be building towards 5p ahead of the main event on 7th June for Lupozor, never in IMM history has it not moved up significantly into an FDA decision date, this time is no different apart from the fact the share price is beaten down, positive news and this multibags a good few times over
Lambo222,
Humility is a great virtue which you seem to have quite a lot of :-)
I believe every word you write , of course …( not )
Watch this rocket next week, i think you miss the point Nolupus people are invested here to make money, been right and acting smart doesn’t make you any money unfortunately, knowing when to buy and sell does…. Two major catalysts due on next week 16th May, one 3 weeks later on 7th June… if FDA are positive on both what do you think the price will be? higher than 2.6p that’s for sure 10p entirely possible you pay your money you take your chance, but over the next few weeks this is going to light up make no mistake
Tuesdays FDA meeting for CIDP could really ignite the fire here and get momentum building ahead of the Lupozor phase 3 FDA approval meeting on 7th June, as we know with IMM once momentum builds it really does motor and we have two company making catalysts coming up, one of which unlocks $25m funding from our US partner Avion in a $10 billion Lupus market that currently only has two treatments with severe side effects, Lupozor is safe and little to no side effects the potential on offer here is mind boggling imo potentially the next world leader in Lupus treatment and the Mcap is £10m… huge rewards on offer for buyers at this level
Lambo222 - you put your left leg in, your left leg out, in out, in out, shake it all about.